Todd Peterson, DO
Adult Reconstructive Orthopaedic Surgery · Clive, IANPI 1407085103
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.7%), education and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Arthrex at 30.8% of the total. Reporting peaked in 2019 at $5,072 and has fallen 91.1% since, to $451 in 2025.
Across 101 payments — averaging $137.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$4K
- Wardlow Enterprises$4K
- Zimmer Biomet$2K
- Smith+Nephew$2K
- Maxx Orthopedics, Inc.$1K
- Stryker$494
- plus $553 from 5 others
What the payments were for
- Travel & lodging$3,10022%
- Food & beverage$6,19645%
- Education$4,55633%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 20 | $4,272 |
| Wardlow Enterprises | 20 | $3,774 |
| Zimmer Biomet | 20 | $1,892 |
| Smith+Nephew | 14 | $1,541 |
| Maxx Orthopedics, Inc. | 13 | $1,326 |
| Stryker | 4 | $494 |
| Prism Medical | 3 | $321 |
| Johnson & Johnson | 4 | $109 |
| Maxx Health Inc | 1 | $83 |
| Heron Therapeutics, Inc. | 1 | $21 |
| Davol Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Navio Surgical System$700
- MAKO$472
- Journey II XR$425
- Journey II BCS$327
- POLARCUP$327
- VISIONAIRE Cutting Guides$319
- Persona$271
- REDAPT Revision Hip System$267
- Legion Revision$267
- Oxford$143
- Tricera Handpiece$139
- LENS 4K$131
- ROSA-Knee$131
- REAL INTELLIGENCE$129
- Journey II$129
- Persona Revision$119
- Ventix Anchor$119
- Gel One$114
- ROSA$105
- TAPESTRY$104
How this compares
Too few adult reconstructive orthopaedic surgery providers in Iowato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 70 | $2,162 |
| Meloxicam | 260 | $611 |
| Diclofenac Sodium | 29 | $135 |
| Amoxicillin | 134 | $93 |
| Clindamycin Hcl | 21 | $16 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Clive
- Omar AkhtarCedar Rapids$533K
- Nicolas NoiseuxIowa City$69K
- Sandeep MunjalCedar Rapids$33K
- Jeffrey NassifCedar Rapids$31K
- David DemikCedar Rapids$14K
- Christopher DickinsonWest Des Moines$9K
- Yogesh KolwadkarSpencer$8K
- Christopher NelsonWest Des Moines$5K
- Ryan PokorneyBettendorf$4K
- Benjamin BeecherDes Moines$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.